(Q23923633)

2

0 references

Michael Vishnevetsky

3

0 references

Victor Adler

4

0 references

Ehsan Sarafraz-Yazdi

5

0 references

Sunming Lou

6

0 references

Jesco Koenke

7

0 references

Vadim Shteyler

8

0 references

Kamran Ikram

9

0 references

Michael Harding

10

0 references

Martin H. Bluth

11

0 references

Mou Ng

12

0 references

Paul W. Brandt-Rauf

13

0 references

Raqibul Hannan

14

0 references

Stephan Bradu

15

0 references

Michael E. Zenilman

16

0 references

Josef Michl

17

0 references

Matthew R. Pincus

Annals of Surgical Oncology

18

0 references

language of work or name

1 reference

18 October 2008

0 references

published in

0 references

volume

15

0 references

issue

12

0 references

page(s)

3588-3600

0 references

performing organization

Columbia University

object named as

Columbia University Health Sciences

1 reference

NIOSHTIC-2

on focus list of Wikimedia project

2 February 2024

Wikimedia–NIOSH collaboration

0 references

1 reference

25 September 2023

Transducible peptide therapy for uveal melanoma and retinoblastoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growth

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death: necrosis versus apoptosis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

Study of the cytotoxic effect of a peptidic inhibitor of the p53-hdm2 interaction in tumor cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

Differences in the ubiquitination of p53 by Mdm2 and the HPV protein E6.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

Coupling of the antennapedia third helix to a potent antagonist of the p53/hdm2 protein-protein interaction

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

NMR solution structure of a peptide from the mdm-2 binding domain of the p53 protein that is selectively cytotoxic to cancer cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding site

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021

The p53-MDM2 interaction in a cancer-prone family, and the identification of a novel therapeutic target

1 reference

https://api.crossref.org/works/10.1245%2FS10434-008-0147-0

7 January 2021